These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8239704)

  • 1. Keratinocyte gene therapy.
    Vogel JC
    Arch Dermatol; 1993 Nov; 129(11):1478-83. PubMed ID: 8239704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous gene transfer and therapy: the present and the future.
    Spirito F; Meneguzzi G; Danos O; Mezzina M
    J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy progress and prospects: the skin--easily accessible, but still far away.
    Hengge UR
    Gene Ther; 2006 Nov; 13(22):1555-63. PubMed ID: 16957767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors.
    Braun-Falco M; Doenecke A; Smola H; Hallek M
    Gene Ther; 1999 Mar; 6(3):432-41. PubMed ID: 10435093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes.
    Sawamura D; Meng X; Ina S; Sato M; Tamai K; Hanada K; Hashimoto I
    J Immunol; 1998 Nov; 161(10):5633-9. PubMed ID: 9820543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.
    Meng X; Sawamura D; Tamai K; Hanada K; Ishida H; Hashimoto I
    J Clin Invest; 1998 Mar; 101(6):1462-7. PubMed ID: 9502789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current approaches and perspectives in human keratinocyte-based gene therapies.
    Del Rio M; Gache Y; Jorcano JL; Meneguzzi G; Larcher F
    Gene Ther; 2004 Oct; 11 Suppl 1():S57-63. PubMed ID: 15454958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards gene therapy for haemophilia B using primary human keratinocytes.
    Gerrard AJ; Hudson DL; Brownlee GG; Watt FM
    Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and prospects of skin gene therapy: a ten year history.
    Hengge UR
    Clin Dermatol; 2005; 23(1):107-14. PubMed ID: 15708294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
    Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G
    Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectable bicistronic vectors in skin gene therapy.
    Scheidemann F; Therrien JP; Pfützner W
    Arch Dermatol Res; 2008 Sep; 300(8):415-23. PubMed ID: 18663457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
    Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
    J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
    Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
    Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of mouse growth hormone by transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy.
    Peroni CN; Cecchi CR; Rosauro CW; Nonogaki S; Boccardo E; Bartolini P
    J Gene Med; 2008 Jul; 10(7):734-43. PubMed ID: 18389487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy and the skin.
    Hengge UR; Bardenheuer W
    Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):93-100. PubMed ID: 15468151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral gene therapy approaches to hemophilia.
    Gómez-Vargas A; Hortelano G
    Semin Thromb Hemost; 2004 Apr; 30(2):197-204. PubMed ID: 15118931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skin and gene therapy. Hopes and realities].
    Descamps V
    Ann Dermatol Venereol; 1995; 122(4):226-34. PubMed ID: 8526417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.